ライフサイエンスコーパス: silver sulfadiazine

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 catheters impregnated with chlorhexidine and silver sulfadiazine.

2 r and was impregnated with chlorhexidine and silver sulfadiazine.

3 showed in vitro resistance to chlorhexidine-silver sulfadiazine.

4 ters coated with chlorhexidine gluconate and silver sulfadiazine.

5 cil with those coated with chlorhexidine and silver sulfadiazine.

6 or a catheter coated with chlorhexidine and silver sulfadiazine.

7 catheters impregnated with chlorhexidine and silver sulfadiazine (28 of 356 catheters [7.9 percent] v

8 Catheters impregnated with silver sulfadiazine and chlorhexidine had a smaller prop

9 p of triple-lumen catheters impregnated with silver sulfadiazine and chlorhexidine.

10 y the use of medium containing inhibitors of silver sulfadiazine and chlorhexidine.

11 n preparation and catheters impregnated with silver sulfadiazine and chlorhexidine; b) to decrease th

12 ated with a combination of chlorhexidine and silver sulfadiazine appear to be effective in reducing t

13 antiseptic combination of chlorhexidine and silver sulfadiazine are efficacious in reducing the inci

14 The chlorhexidine-silver sulfadiazine catheter is well tolerated, reduces

15 The second-generation chlorhexidine-silver sulfadiazine catheter is well tolerated.

16 ida were cultured from the chlorhexidine and silver sulfadiazine central venous catheters.

17 eptic catheter coated with chlorhexidine and silver sulfadiazine (CH/SS).

18 sess the impact of the antiseptic effects of silver sulfadiazine-chlorhexidine-impregnated central ve

19 uracil were noninferior to chlorhexidine and silver sulfadiazine coated central venous catheters with

20 in 0.5% AgNO3 and 5 times lower than that in silver sulfadiazine cream 1%.

21 an agar plate, and about 6 times faster than silver sulfadiazine cream.

22 acil group and 0.9% of the chlorhexidine and silver sulfadiazine group.

23 episodes were noted in the chlorhexidine and silver sulfadiazine group.

24 catheters impregnated with chlorhexidine and silver sulfadiazine have recently been introduced for th

25 r analyses suggest that use of chlorhexidine-silver sulfadiazine-impregnated central venous catheters

26 Randomized trials comparing chlorhexidine-silver sulfadiazine-impregnated central venous catheters

27 Short-term use (2-10 days) of chlorhexidine-silver sulfadiazine-impregnated multilumen central venou

28 l venous catheters; and use of chlorhexidine-silver sulfadiazine-impregnated or minocycline-rifampin-

29 than catheters coated with chlorhexidine and silver sulfadiazine in preventing colonization and infec

30 -fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480).

31 and external surfaces) or chlorhexidine and silver sulfadiazine (on only the external surface).

32 ters coated with chlorhexidine gluconate and silver sulfadiazine (P < .01).

33 for those impregnated with chlorhexidine and silver sulfadiazine; P<0.002).

34 inocycline and rifampin or chlorhexidine and silver sulfadiazine reduces the rates of catheter coloni

35 , 0.34 [95% CI, .14-.82]), and chlorhexidine-silver sulfadiazine (RR, 0.60 [95% CI, .50-.72]) impregn

36 ifampin and with chlorhexidine gluconate and silver sulfadiazine were evaluated.

37 ers externally coated with chlorhexidine and silver sulfadiazine when used in critically ill patients

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。